AbbVie (ABBV)

Frequently Asked Questions About AbbVie (ABBV)

How can patients access AbbVie’s medications?

Patients can access AbbVie’s medications through various channels, including pharmacies, healthcare providers, and specialty pharmacies. AbbVie provides resources for patients, including financial assistance programs and educational materials, to help them navigate their treatment options and understand how to access their prescribed therapies.

How does AbbVie approach research and development?

AbbVie emphasizes a rigorous research and development (R&D) strategy that combines advanced scientific techniques with a focus on patient needs. The company invests significantly in R&D, collaborating with various organizations, universities, and research institutes to enhance its innovation capabilities. AbbVie aims to develop products that offer unique benefits over existing treatments and address gaps in care.

How does AbbVie handle drug pricing?

AbbVie navigates the complex landscape of drug pricing by balancing the need for fair access to its therapies with the substantial costs involved in research, development, and manufacturing. The company engages with healthcare stakeholders, including payers and patients, to ensure affordability while continuing to invest in innovation that can lead to breakthrough therapies.

How does AbbVie support patient advocacy?

AbbVie actively supports patient advocacy organizations to raise awareness about various health conditions and enhance patient support. The company collaborates with these groups to share educational resources, promote research, and ensure that the voices of patients are heard in discussions about healthcare policies and access to treatments.

How has AbbVie advanced in immunology?

AbbVie has made substantial advancements in immunology through its research and development efforts. The company has developed several leading therapies targeting autoimmune diseases, including Humira and Rinvoq. AbbVie continues to explore novel approaches and biological treatments to improve the quality of life for patients suffering from chronically debilitating conditions.

Is AbbVie involved in corporate social responsibility?

Yes, AbbVie is actively engaged in corporate social responsibility (CSR) initiatives that aim to improve health outcomes globally. The company supports various charitable programs, promotes health education, and emphasizes access to healthcare in underserved communities. AbbVie is committed to sustainability practices, which include reducing its environmental impact and promoting diversity and inclusion within the workplace.

What are some of AbbVie's key products?

Some of AbbVie's key products include Humira (adalimumab), Imbruvica (ibrutinib), Venclexta (venetoclax), Rinvoq (upadacitinib), and Skyrizi (risankizumab). Each of these therapies addresses critical health issues like autoimmune disorders, blood cancers, and skin conditions, demonstrating AbbVie's commitment to meeting significant healthcare challenges.

What does AbbVie do?

AbbVie is a global biopharmaceutical company that specializes in the development and commercialization of advanced therapies to treat severe diseases. The company focuses on areas such as immunology, oncology, virology, neurology, and women's health. AbbVie is known for its innovative products, including its flagship drug Humira, which has been used to treat autoimmune conditions. Their commitment to research and development enables them to address unmet medical needs around the world.

What future plans does AbbVie have for growth?

AbbVie plans to continue its growth trajectory by focusing on innovation, expanding its product portfolio, and seeking new market opportunities. The company is investing in emerging therapies, particularly in oncology and immunology, while also exploring partnerships and acquisitions that align with its strategic goals to enhance its therapeutic capabilities.

What is AbbVie's strategy for innovation?

AbbVie’s strategy for innovation involves a commitment to continuous investment in R&D, leveraging advanced technologies, and fostering strategic partnerships. The company collaborates with academic institutions, biotech firms, and research organizations to enhance its innovation pipeline. AbbVie encourages a culture of scientific curiosity and exploration, aiming to discover new treatments that can transform patient care.

What is AbbVie’s approach to diversity and inclusion?

AbbVie values diversity and inclusion as critical components of its business strategy. The company is dedicated to fostering an inclusive workforce that reflects the diverse communities it serves. AbbVie implements policies and practices that promote equality in hiring and career advancement while providing training and resources to create an inclusive environment where all employees can thrive.

What is AbbVie’s mission statement?

AbbVie's mission is to use its expertise to develop and market advanced therapies that improve patients' lives. The company strives to address serious health issues and deliver innovative solutions that empower healthcare providers and patients alike. AbbVie is dedicated to fostering a culture of integrity, trust, and accountability in all its endeavors.

What is AbbVie’s stock symbol and market presence?

AbbVie is publicly traded on the New York Stock Exchange under the ticker symbol ABBV. The company has a strong market presence and is part of major indices, which reflects its significance in the biopharmaceutical sector. AbbVie has consistently focused on delivering value to its shareholders while advancing its product portfolio and pipeline.

What is the significance of Humira for AbbVie?

Humira has been one of AbbVie's most significant products, achieving blockbuster status due to its widespread use in treating various autoimmune conditions, including rheumatoid arthritis and Crohn’s disease. The drug has generated substantial revenue, enabling AbbVie to invest in its R&D and expand its portfolio. However, with the expiration of its patent and the introduction of biosimilars, Humira's market dominance is facing new challenges.

What kind of clinical trials does AbbVie conduct?

AbbVie conducts a wide range of clinical trials to evaluate the safety and efficacy of its drug candidates. These trials span various phases, from early-stage studies to late-stage pivotal trials. AbbVie’s robust clinical trial program is essential for bringing new therapies to market and often involves collaboration with healthcare institutions and research organizations worldwide.

What recent acquisitions has AbbVie made?

AbbVie has pursued strategic acquisitions to bolster its portfolio and expand its capabilities. A notable acquisition was the purchase of Allergan in 2020, which significantly enhanced AbbVie's pipeline, particularly in aesthetics and central nervous system disorders. This acquisition exemplifies AbbVie’s commitment to diversifying its offerings and addressing broader healthcare needs.

What therapeutic areas does AbbVie focus on?

AbbVie concentrates its efforts on several critical therapeutic areas, including immunology, oncology, virology, neuroscience, and women's health. This focus allows the company to leverage its research expertise and develop targeted therapies that address diverse and significant health challenges faced by patients worldwide.

When was AbbVie founded?

AbbVie was founded in October 2012 as a spinoff from Abbott Laboratories, a company that has a long history in the healthcare sector dating back to 1888. Since its inception, AbbVie has been focused on developing innovative therapies and has grown rapidly through both internal research and strategic acquisitions.

Where is AbbVie headquartered?

AbbVie is headquartered in North Chicago, Illinois, United States. Its location allows the company to be at the center of the biopharmaceutical industry's research and development activities, and it provides easy access to a diverse talent pool and partnerships with academic institutions and healthcare organizations.

What is the current price of AbbVie?

The current price of AbbVie is 205.19

When was AbbVie last traded?

The last trade of AbbVie was at 4:10 pm EDT on April 2nd, 2025